Back

Renilon 7.5

Features
  • 250kcal/bottle (2kcal/ml): energy-dense ONS^ for patients requiring fluid or volume restriction.
  • 9.4g protein/bottle (15% energy): moderate protein to aid in the dietary management of protein-energy malnutrition, frequently observed in patients on dialysis.1
  • Reduced mineral content (sodium, potassium, chloride, calcium, phosphorus, magnesium): for patients that require select mineral restriction.
  • Elevated levels of micronutrients with antioxidant properties (copper, manganese, slenium,carotenoids, vitamin E, riboflavin, vitamin B6 folic acid, vitamin B12) compared to standard ONS^: to support and mitigate increased oxidative stress in pre-dialysis patients.2-13
  • Does not contain preformed vitamin A: to prevent hypervitaminosis.14-18
  • Does not contain vitamin D: to reduce the risk of toxicity as vitamin D cannot be converted sufficiently to active form by patients with end-stage renal failure.19

Product Information

A ready-to-drink, high energy, moderate protein, reduced mineral oral nutritional supplement for the dietary management of patients with renal disease (receiving dialysis).

Link copied!
Indications

For the dietary management of:

  • Disease-related malnutrition.
  • Patients with renal disease receiving dialysis treatment.
  • Patients requiring a fluid or volume restriction.
  • Patients requiring a select mineral restriction.
Important Notice
  • Not suitable as a sole source of nutrition.
  • Not suitable for parenteral use.
  • Not suitable for patients with galactosaemia.
  • Not suitable for patients with cow’s milk protein allergy.
  • Not suitable for infants and children under 3 years of age.
  • Use with caution in children aged 3 years+.
  • Must be used under medical supervision.
Direction for Use
  • Shake well before use.
  • Best served chilled.
  • Usage to be determined by a healthcare professional.
Storage
  • Store in a cool, dry place.
  • Once opened, close the bottle and store in a refrigerator for maximum 24 hours.
Order Information

To order Contact Nutricia Experience 1800 889 480

Renilon 7.5 Presentation Code Units per carton
Caramel 125ml bottle 177025 24
Ingredients

Full ingredients list and nutritional information is available on the product fact sheet.

Allergen & Cultural Information
  • Contains milk and soy.
  • Halal certified.
  • Nutricia UK and/or Ireland has Kosher approval for this product.
  • No gluten containing ingredients. No detectable gluten when tested to a sensitivity level of less than 5 parts per million (<5 ppm i.e. <5mg/kg).
  • Low lactose (lactose <2g/100g).
References
  1. Herselman M, Moosa MR, Kotze TJ, Kritzinger M, Wuister S, Mostert D. Protein-energy malnutrition as a risk factor for increased morbidity in longterm hemodialysis patients. J Renal Nutr 2000; 10: 7-15.
  2. Drai J, Bannier E, Chazot C, Hurot J et al. Oxidants and antioxidants in longterm haemodialysis patients. Farmaco 2001; 56: 463-65.
  3. Morena M, Cristol J, Canaud B. Why hemodialysis patients are in a prooxidant state? What could be done to correct the pro/antioxidant imbalance. Blood Purif 2000; 18: 191-99
  4. Loughrey CM, Young IS, Lightbody JH et al. Oxidative stress in haemodialysis. QJM 1994; 87: 679-83.
  5. Toborek M, Wasik T, Drozdz M, Klin M et al. Effect of hemodialysis on lipid peroxidation and antioxidant system in patients with chronic renal failure. Metabolism 1992; 41: 1229-32.
  6. Chen CK, Liaw JM, Juang JG, Lin TH. Antioxidant enzymes and trace elements in hemodialyzed patients. Biol Trace Elem Res 1997; 58: 149-57.
  7. Paul JL, Sall ND, Soni T et al. Lipid peroxidation abnormalities in hemodialyzed patients. Nephron 1993; 64: 106-109.
  8. Stratton R. Rationale for the addition of carotenoids to enteral tube and sip feeds. Nutricia Healthcare 2000, on file.
  9. Ghoreshi Z, Jagtap PE, Ahaley SK, Gandhi R. Oxidant-antioxidant status in acute and chronic renal failure. Indian J Med Sci 2000; 54: 131-135.
  10. Jackson P, Loμghrey CM, Lightbody JH, McNamee PT, Young IS. Effect of hemodialysis on total antioxidant capacity and serum antioxidants in patients with chronic renal failure. Clin Chem 1995; 41: 1135-38.
  11. Fiorillo C, Oliviero C, Rizzuti G et al. Oxidative stress and antioxidant defenses in renal patients receiving regular haemodialysis. Clin Chem Lab Med 1998; 36: 149-153.
  12. Bender DA, Bender AE. Nutrition. A reference handbook. Oxford: Oxford University Press, 1997.
  13. Okada A, Takagi Y, Nezu R, Sando K, Shenkin A. Trace element metabolism in parenteral and enteral nutrition. Nutrition 1995; 11(Suppl): 106-11
  14. Muth I. Implications of hypervitminosis A in chronic renal failure. J Renal Nutr 1991; 1: 2-8.
  15. Khan IH, Richmond P, Macleod AM. Diseases of the kidneys and urinary tract. In: Garrow JS, James WPT, Ralph A (eds). Human nutrition and dietetics. Tenth edition. Edinburgh; Churchill Livingstone; 2000; 667-687.
  16. Goldstein DJ, Abrahamian-Gebeshian C. Nutrition support in renal failure. In: Matarese LE, Gottschlich MM (eds). Contemporary Nutrition Support Practice. A Clinical Guide. Philadelphia: WB Saunders 1998; 447-47.
  17. Ha TK, Sattar N, Talwar D, Cooney J, Simpson K, O’Reilly DS et al. Abnormal antioxidant vitamin and carotenoid status in chronic renal failure. QJM 1996; 89: 765-769.
  18. Allman MA, Truswell AS, Tiller DJ, Stewart PM et al. Vitamin supplementation of patients receiving haemodialysis. Med J Aust 1989; 150: 130-133.
  19. Hartley G, Roberts R. Renal Disease. Thomas B (ed). Manual of Dietetic Practice, 3rd ed. Oxford: Blackwell Scientific Publications 2001; 420-434.
Additional Information

^Oral Nutritional Supplement